Statements (79)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Smith_Kline_Beecham
strategic acquisitions |
| gptkbp:audience |
focus on employee engagement
|
| gptkbp:benefits |
comprehensive employee benefits
|
| gptkbp:ceo |
gptkb:Emma_Walmsley
|
| gptkbp:clinical_trial |
ongoing
collaborations with universities conducts clinical trials conducts healthcare research influences clinical practice utilizes clinical data |
| gptkbp:collaborations |
engages in research collaborations
|
| gptkbp:community_engagement |
health education programs
|
| gptkbp:cultural_representation |
commitment to employee diversity
|
| gptkbp:developer |
diverse global workforce
|
| gptkbp:dividend_yield |
regular dividends paid
|
| gptkbp:education |
provides patient education resources
|
| gptkbp:employees |
99,000 (2020)
|
| gptkbp:environmental_impact |
committed to environmental responsibility
|
| gptkbp:founded |
gptkb:2000
|
| gptkbp:global_presence |
over 100 countries
|
| gptkbp:headquarters |
gptkb:Brentford,_England
|
| gptkbp:healthcare |
supports community health initiatives
enhances healthcare delivery improves healthcare access improving patient access contributes to global health initiatives drives healthcare innovation investments in digital health provides healthcare solutions |
| https://www.w3.org/2000/01/rdf-schema#label |
GSK Pharmaceuticals
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:innovation |
focus on innovation
drives innovation strategy |
| gptkbp:invention |
numerous pharmaceutical patents
|
| gptkbp:investment |
investments in biotechnology
|
| gptkbp:is_vulnerable_to |
active in vaccine development
|
| gptkbp:language_of_instruction |
diverse product pipeline
|
| gptkbp:market |
conducts market research
|
| gptkbp:market_cap |
approximately $100 billion (2021)
|
| gptkbp:marketing_strategy |
global market strategy
|
| gptkbp:partnership |
gptkb:Sanofi
gptkb:Pfizer gptkb:Novartis |
| gptkbp:partnerships |
collaborative partnerships
partnerships with healthcare providers develops healthcare partnerships |
| gptkbp:philanthropy |
philanthropic initiatives
|
| gptkbp:products |
antibiotics
vaccines antidepressants |
| gptkbp:provides_information_on |
contributes to clinical guidelines
|
| gptkbp:regulatory_compliance |
ensures regulatory compliance
various regulatory approvals |
| gptkbp:research |
supports scientific research
|
| gptkbp:research_and_development |
significant investment
|
| gptkbp:research_areas |
multiple therapeutic areas
|
| gptkbp:research_focus |
oncology
immunology respiratory diseases |
| gptkbp:revenue |
$43 billion (2020)
|
| gptkbp:safety_features |
prioritizes patient safety
|
| gptkbp:social_responsibility |
active CSR programs
|
| gptkbp:specialties |
pursues clinical excellence
|
| gptkbp:stock_exchange |
gptkb:London_Stock_Exchange
|
| gptkbp:subsidiary |
gptkb:Vii_V_Healthcare
gptkb:Consumer_Healthcare HIV treatments |
| gptkbp:supply_chain |
global supply chain management
focus on supply chain sustainability |
| gptkbp:sustainability_initiatives |
carbon neutrality by 2030
|
| gptkbp:symbol |
gptkb:GSK
|
| gptkbp:training |
extensive employee training programs
|
| gptkbp:treatment |
focus on improving health outcomes
focus on improving clinical outcomes |
| gptkbp:bfsParent |
gptkb:Glaxo_Wellcome
gptkb:Smith_Kline_Corporation |
| gptkbp:bfsLayer |
5
|